Observational studyBMC nephrology2026
An early risk assessment model for sepsis-associated acute kidney injury based on CEUS and biomarkers.
Observational study in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSepsis-associated acute kidney injury (SA-AKI) is a common and serious complication in critically ill patients, leading to increased morbidity and mortality. This study aims to develop a model for early identification and risk assessment of SA-AKI based on contrast-enhanced ultrasound (CEUS) and biomarkers.
methodsThis retrospective observational study included 152 septic patients admitted to the Surgical Intensive Care Unit (SICU) of Zhongshan Hospital from January 2021 to June 2022. Patients were divided into training and validation cohorts. Clinical data, CEUS-derived parameters, and biomarkers were collected within 24 h of admission. A risk assessment model was developed using least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression. Model performance was assessed by the area under the receiver operating characteristic curve (AUROC) and calibration. The primary outcome was AKI occurring within 48 h of ICU admission.
resultsSA-AKI occurred in 86 patients (56.6%). Four independent predictors—urinary neutrophil gelatinase-associated lipocalin (NGAL), serum cystatin C, renal resistive index (RRI), and medullary wash-in slope (WIS)—were identified. The model demonstrated high discriminative performance, with AUROCs of 0.96 in the training cohort and 0.93 in the validation cohort. Sensitivity and specificity were 82.8% and 91.1% in the training cohort, and 75.0% and 88.9% in the validation cohort. Decision curve analysis (DCA) demonstrated favorable net clinical benefit across a wide range of thresholds.
conclusionWe developed a noninvasive model integrating CEUS-derived microcirculatory metrics and renal biomarkers for early identification and risk assessment of SA-AKI at ICU admission. This model may help clinicians prioritize surveillance and renal-protective strategies in the early phase of sepsis care. Given the single-center retrospective design and internal validation, external validation in independent multicenter cohorts is essential before any clinical implementation, and the generalizability of these findings should not be assumed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.